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1.  Introduction 1 
Pregnant women have higher rates of influenza-related hospitalizations [1], complications [2, 2 
3], and mortality [2, 4] during pandemic and non-pandemic years. Influenza vaccination is 3 
beneficial and safe for pregnant women throughout pregnancy [5-8] and provides protection 4 
for the newborn in the first 6 months of life [9]. Although the World Health Organization 5 
(WHO) has identified pregnant women as having highest priority for seasonal influenza 6 
vaccination [10], maternal influenza vaccination rates are often lower than in other high-risk 7 
groups and the general population [11-13]. A recent review of influenza vaccination rates in 8 
pregnant women across 11 countries found vaccination rates ranged from 1.7%–88%, but 9 
were most often less than 50% [14]. 10 
Pregnant women who have more knowledge about the potential complications of 11 
influenza and the safety of the influenza vaccine are more likely to be vaccinated [15-17]. To 12 
date, the majority of interventions aimed at improving maternal influenza vaccination rates 13 
have targeted healthcare providers, primarily obstetricians, and encouraged them to discuss 14 
influenza vaccination with pregnant women [18-22]. Among pregnant woman-focused 15 
interventions, one trial showed that an education pamphlet, with or without a verbalized 16 
benefits statement, increased vaccination rates [23]. In other studies, one found that 5 weekly 17 
text messages to pregnant women about the importance of maternal influenza vaccination 18 
significantly increased vaccine uptake [24] while another found that 12 weekly text messages 19 
had no effect on maternal vaccination rates [25]. Chamberlain et al. [26] found that a multi-20 
component vaccination promotion intervention consisting of provider to patient education, 21 
educational brochures, and an electronic patient-centred tutorial did not improve vaccine 22 
uptake. Frew et al. [27] evaluated the effect of two types of vaccination messages (i.e., 23 
information about the benefits of vaccination vs. information about the risks of not 24 
vaccinating) and found that neither of the two message types significantly improved 25 
vaccination uptake.  26 
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The low rate of vaccine uptake in this target group and the conflicting evidence from 27 
evaluated interventions indicate a need to further develop interventions to improve maternal 28 
influenza vaccine rates. Although the Hong Kong government has endorsed the WHO 29 
recommendation for prioritizing pregnant women in seasonal and pandemic influenza 30 
vaccination programs, there is no free or subsidized vaccination program for this target group 31 
and publicly-funded antenatal clinics do not provide influenza vaccination as part of routine 32 
care to pregnant women. Pregnant women must get vaccinated in private clinics, primarily 33 
general practice clinics dispersed throughout the city. In public antenatal clinics, pregnant 34 
women do not have a dedicated provider and at each visit are assessed by a midwife or 35 
physician, depending on their stage of pregnancy and any complicating conditions. Thus, 36 
provider-focused interventions would likely be ineffective in such settings and interventions 37 
targeting pregnant women may be more appropriate to improve influenza vaccination 38 
coverage. The objective of the present study was to assess the effect of a brief education 39 
intervention targeting pregnant women on the uptake of influenza vaccination.  40 
 41 
2.  Materials and Methods 42 
2.1  Design, setting, and participants 43 
We designed a randomized controlled trial to evaluate the efficacy of a brief, one-to-one 44 
education session on the influenza vaccination rate during pregnancy and the proportion of 45 
participants seeking out influenza vaccination. A more detailed study protocol is reported 46 
elsewhere [28]. During two consecutive influenza seasons (2013-14 and 2014-15), pregnant 47 
women attending the antenatal clinics at four geographically-dispersed public hospitals in 48 
Hong Kong were screened for eligibility and recruited into the study by a research nurse. 49 
These hospitals were selected based on geographical representativeness and the large 50 
populations of eligible pregnant women from a wide range of socioeconomic backgrounds 51 
they served. Hong Kong has eight public and ten private hospitals that offer obstetric services. 52 
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Public health care, including high-quality antenatal, postnatal and well-child health care, is 53 
available free of charge to all Hong Kong residents. Private health care is available on a fee 54 
for service basis. In 2011, two-thirds of all Hong Kong women gave birth in public hospitals 55 
[29]. Although women giving birth in private hospitals are usually of higher socioeconomic 56 
status, many high-income families chose to access public maternity services because it is free, 57 
high quality and comprehensive.  58 
Inclusion criteria were pregnant women: (a) with a singleton pregnancy; (b) at least 18 59 
years of age; (c) in at least the second trimester of pregnancy; (d) who spoke Cantonese; (e) 60 
were Hong Kong residents; (f) without serious medical conditions (i.e., cancers, rheumatoid 61 
arthritis, major psychiatric illnesses) or obstetrical complications (i.e., full placenta previa or 62 
diagnosed birth defects); (g) who had not yet received the influenza vaccination during this 63 
pregnancy; and (h) who would be staying in Hong Kong for at least 2 weeks after birth. Non-64 
residents who are not entitled to health benefits in Hong Kong were excluded. Although 65 
influenza vaccine is safe in any trimester of pregnancy, we recruited pregnant women after 66 
the first trimester to avoid any perceived association between vaccination and early pregnancy 67 
complications.  68 
 69 
2.2  Randomization and concealment 70 
Participating pregnant women were randomized into either a standard care group or an 71 
intervention group at a 1:1 ratio, using block randomization with random block sizes of 2–8. 72 
An independent researcher who did not participate in the study generated an allocation 73 
sequence using Stata 13.1 statistical software (StataCorp 2013, Stata Statistical Software: 74 
Release 13, College Station, TX; StataCorp LP). Treatment assignments were placed in 75 
sequentially numbered, sealed, opaque envelopes. The research nurse selected the next 76 
envelope in the sequence to determine treatment allocation, after the eligible pregnant women 77 
  4 
were given information about the study and had signed a written consent form. Blinding of 78 
the research nurse and participants was not possible given the nature of the intervention. 79 
 80 
2.3  Intervention 81 
Standard antenatal care consists of routine checking of maternal and fetal health by either 82 
obstetricians or midwives, along with health education to promote a healthy pregnancy. 83 
Childbirth preparation classes were available to all women attending the clinics for no 84 
additional cost. Recommendations and education about influenza vaccination in pregnancy 85 
are not normally included in routine antenatal care. However, participants allocated to the 86 
standard care group were provided with an education pamphlet on influenza vaccination in 87 
pregnancy, developed by the Hong Kong Centre for Health Protection (CHP) [30] and freely 88 
available in the antenatal clinics during the study.  89 
The intervention group received standard care plus brief one-to-one education lasting 90 
10 minutes that focused on four key recommendations identified from the literature: (i) 91 
informing the participants about vaccination recommendations; (ii) encouraging them to 92 
discuss vaccination with their antenatal care provider or general practitioner (GP); (iii) 93 
increasing accessibility of the vaccine by referral to clinics where vaccination could be 94 
obtained; and (iv) providing influenza-related information from the official government 95 
website and the website uniform resource locator [14]. Specifically, participants in the 96 
intervention group were informed about: (i) the WHO [10] and Hong Kong CHP 97 
recommendations [31] regarding influenza vaccine during pregnancy; (ii) potential 98 
complications associated with influenza infection during pregnancy and for young infants; 99 
(iii) the safety of influenza vaccination for pregnant women; (iv) potential benefits of 100 
influenza vaccination for pregnant women and infants; and (v) where and how to get the 101 
influenza vaccination in Hong Kong. Almost all participants had a personal GP who provided 102 
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influenza vaccine and for the few that did not, we provided information on nearby clinics that 103 
could provide vaccination.  104 
Immediately after randomization, the intervention was delivered in a private room in 105 
the antenatal clinics so that participants in the standard care group were unable to overhear the 106 
education intervention and to ensure that all participants were unaware of the intervention 107 
other participants received. A digital flip chart was used to present the education content and 108 
participants were encouraged to express concerns and ask questions. To ensure consistency of 109 
intervention delivery, one research nurse carried out the education intervention across the four 110 
sites.  111 
 112 
2.4  Data collection 113 
All participants completed a standard baseline questionnaire collecting: (i) key background 114 
data (i.e., age, marital status, education level, family income, and employment status); (ii) 115 
maternal health status (i.e., pre-existing health conditions, pregnancy-related health problems, 116 
gravidity and parity, and expected date of confinement); and (iii) influenza and influenza 117 
vaccine knowledge. Participants were subsequently followed up by telephone at 2–3 weeks 118 
after their expected delivery date by a study research assistant who had not been involved in 119 
participant recruitment and was blinded to participants’ treatment allocation. During the 120 
follow-up telephone interviews, participants reported their influenza vaccination status during 121 
the pregnancy, reasons for receiving or not receiving influenza vaccination, discussion of 122 
influenza vaccination with antenatal care providers or GPs, attempts to receive the 123 
vaccination (i.e., participant went to their GP and requested the vaccine but were unable to 124 
receive it), and anti-vaccination advice from any healthcare professional. 125 
126 
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2.5  Outcome measures 127 
The primary study outcome was the self-reported influenza vaccination rate during pregnancy. 128 
The secondary outcomes were the proportion of participants who initiated discussion about 129 
influenza vaccination with a healthcare professional and the proportion of participants who 130 
attempted to get vaccinated. 131 
 132 
2.6  Sample size calculation 133 
Previous Hong Kong studies showed that seasonal influenza vaccination uptake among 134 
pregnant women ranged from 1.7%–5% [15, 32, 33]. Other studies also showed that in 135 
pregnant woman-focused interventions, the risk difference of influenza vaccination uptake 136 
among pregnant women before and after implementing the intervention ranged from 2% to 137 
39% [23-25, 27]. Therefore, an estimate of the “normal” influenza vaccination uptake rate 138 
among pregnant women in Hong Kong would be 5.0%, and an increase to 20% would be 139 
conservative but clinically meaningful. With a power of 0.80 and significance level of 0.05 140 
and using a chi-square test in the G-power statistical analysis program [34], we calculated that 141 
76 participants would be required for each group (152 participants in total). After accounting 142 
for a loss to follow-up and dropout rate of around 20%, approximately 92 participants per 143 
group were required, giving a total of 184 participants.  144 
 145 
2.7  Data analysis 146 
Baseline sociodemographic characteristics of the two groups were compared using a 2 test or 147 
a Fisher’s Exact Test for categorical variables and Student’s t-test for continuous variables. 148 
The proportion of participants in the two study groups who received influenza vaccination 149 
during pregnancy was compared using 2 tests. We further computed the odds ratios of 150 
vaccination using logistic regression, while adjusting for one baseline variable that was 151 
significantly different between the two groups. The intention-to-treat principle was used, with 152 
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missing values taken as no vaccination while the per-protocol analysis, with missing values 153 
removed, was reported as a comparison. We used 2 tests to compare the proportion of 154 
participants in the two groups who discussed influenza vaccination with a healthcare 155 
professional and the proportion of participants who attempted to receive influenza vaccination. 156 
Each estimate was accompanied by a 95% confidence interval (CI); a 5% level of significance 157 
was considered statistically significant in all statistical tests. Data analyses were performed 158 
using Stata statistical software (StataCorp 2015, Stata Statistical Software: Release 14.1, 159 
College Station, TX; StataCorp LP)  [35]. 160 
 161 
2.8  Ethical approval 162 
Ethical approval for the study was obtained from: (1) the Institutional Review Board of the 163 
University of Hong Kong/ Hospital Authority Hong Kong West Cluster; (2) the Kowloon 164 
West Cluster Research Ethics Committee (KWC-REC); and (3) the Ethics Committee of 165 
Hong Kong East Cluster (EC-HKEC). Informed written consent was obtained from all study 166 
participants before any personal data were collected and the intervention delivered. The 167 
research nurse informed each eligible pregnant woman about the purpose and nature of the 168 
study, the potential benefits and risks of participation, and their right to refuse to participate or 169 
withdraw at any time during the study without affecting the antenatal care they received.   170 
 171 
3.  Results 172 
Data were collected from October 7, 2013, to February 4, 2014 (Year 1), and from October 20, 173 
2014, to December 23, 2014 (Year 2) (Figure 1). Data collection was interrupted in the first 174 
year when several cases of H7N9 avian influenza were admitted to Hong Kong public 175 
hospitals. Because of the raised influenza threat level, non-essential clinical duties were 176 
suspended in all public hospitals from December 7, 2013, through January 19, 2014. 177 
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Therefore, to achieve the required sample size, recruitment was resumed in the next influenza 178 
season. In total, 489 pregnant women were assessed for eligibility across all sites (Figure 1). 179 
Of these, 6% (n=29) did not meet the eligibility criteria, and 29% (n=140) declined to 180 
participate. Of the 321 who consented to participate, 160 were randomized to the standard 181 
care group and 161 to the intervention group; 305 (95%) participants completed follow-up. 182 
Nine participants were lost to follow-up, and seven were contacted but refused to complete 183 
follow-up. The treatment fidelity rate was 100%, because the intervention was delivered 184 
immediately after randomization.  185 
An overview of participants’ characteristics is presented in Table 1. The two groups 186 
were similar, except for a significantly higher proportion of participants with a pre-existing 187 
chronic illness in the intervention group (p=0.006). The reported pre-existing chronic illnesses 188 
were Hepatitis B carrier status (n=14), respiratory disease (n=6), thyroid disease (n=6), and 189 
others (n=13). The influenza vaccination rate for all participants was 15.6% (n=50) with a 190 
higher proportion of vaccinated participants in the intervention group (21.1%, n=34) than the 191 
standard care group (10%, n=16) (risk difference [RD] 11.1; 95% CI 3.3–19.0; p=0.006) (see 192 
Table 2). The number needed to treat was 9 (95% CI 5.3–30.4). After excluding those lost to 193 
follow-up, 22.5% (n=34) of participants in the intervention group received vaccination 194 
compared with 10.4% (n=16) in the standard care group (RD 12.1%; 95% CI 3.9–20.3; 195 
p=0.004). The logistic regression analysis showed that after adjusting for pre-existing chronic 196 
disease status, the intervention group was still significantly more likely to be vaccinated in the 197 
intention-to-treat analysis (odds ratio [OR] 2.45; 95% CI 1.28–4.68; p=0.007) and the per-198 
protocol analysis (OR 2.52; 95% CI 1.32–4.82; p=0.005). There were no substantive 199 
differences in the vaccination uptake rates of participants between the two study years (see 200 
Supplementary Table).  201 
The proportion of participants who initiated discussion about influenza vaccination 202 
with a healthcare professional was higher among participants in the intervention group 203 
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(19.9%; n=32) than in the standard care group (13.1%; n=21), but the difference was not 204 
statistically significant (p=0.10). Of participants who did not receive influenza vaccination 205 
during pregnancy (n=271), 45 reported that they had attempted to get vaccinated. A 206 
significantly higher proportion of participants who attempted to get vaccinated were in the 207 
intervention group (82.2%; n=37) than in the standard care group (17.8%; n=8) (p<0.001). If 208 
participants who made the attempt had received the vaccination, the vaccination rate would 209 
have been 44.1% (n=71) in the intervention group and 15% (n=24) in the standard care group 210 
(RD 29.1%, 95% CI 19.6%–38.6%, p<0.001) (Table 3). At baseline, only 6.2% (n=20) of 211 
participants reported that a healthcare professional had discussed influenza vaccination with 212 
them. At follow-up, 8.5% (n=26) of participants reported that they were advised against 213 
influenza vaccine by a healthcare professional, which included obstetricians (n=11), general 214 
practitioners (n=8), and nurses (n=7). 215 
 216 
4.0  Discussion 217 
The results of this study show that a brief, one-to-one education intervention for pregnant 218 
women significantly increased maternal influenza vaccination. However, the vaccination rate 219 
in the intervention group (21.1%) was still substantially below the Healthy People 2020 target 220 
vaccination rate of 80% [36]. This may be because other supportive vaccination practices (e.g., 221 
on-site vaccine availability and positive recommendations from their obstetric healthcare 222 
provider) were not in place. Pregnant women needed to obtain the vaccination from a private 223 
provider, which increased vaccination barriers. In obstetric settings where vaccination is 224 
readily available however, the effectiveness of brief education may be greater as the barriers 225 
that exist in our setting would be removed. Furthermore, when our participants did attempt to 226 
get vaccinated, many were advised against vaccination by a healthcare professional or were 227 
unable to receive the vaccine. If these participants had received vaccination, the vaccination 228 
rate in the intervention group would have been approximately twice as high.  229 
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The relationship between healthcare professionals, pregnant women and influenza 230 
vaccination is complex. Studies show that doctors and nurses frequently recommend 231 
influenza vaccination to elderly or chronically ill clients or people perceived to be at highest 232 
risk from influenza morbidity and mortality [37-39]. However, healthcare professionals are 233 
less likely to recommend vaccination for young healthy populations [40-42]. Furthermore, 234 
rates of influenza vaccination among healthcare professionals, an identified risk group, are 235 
consistently low [43-45]. Studies of US obstetric healthcare providers have found that over 236 
85% report that they routinely recommend influenza vaccine to their pregnant patients [20, 46, 237 
47]. Other studies however, suggest that many obstetric healthcare providers are unaware of 238 
vaccine recommendations for pregnant women and even if aware, are reluctant to recommend 239 
vaccination [40, 42, 48, 49]. In addition, surveys of pregnant women have found that only 7–240 
40% report receiving such a recommendation [32, 33, 50-52]. Although pregnant women who 241 
receive a vaccination recommendation from their healthcare provider are substantially more 242 
likely to receive influenza vaccination [14], only 30–70% of pregnant women receiving the 243 
recommendation get vaccinated [33, 50-52]. This suggests that even with knowledge of the 244 
benefits of vaccination, many pregnant women remain reluctant to get vaccinated. This 245 
reluctance is likely due to an long-held belief system that pregnant women should minimize 246 
exposing the fetus to any unknown or potentially adverse substances [46], especially those 247 
injected into the body. Evidence has shown that interventions targeting healthcare 248 
professionals improved maternal influenza vaccination rates [18, 21, 53]. In our study a nurse 249 
delivered the education intervention and recommended the vaccination to participants, and 250 
although vaccine uptake was significantly improved, rates were still suboptimal. Pregnant 251 
women may be more willing to follow recommendations from their regular GP or obstetric 252 
healthcare provider but some women may still be reticent to receive the vaccination during 253 
pregnancy [54]. In addition to maternal education, enthusiastic vaccination recommendations, 254 
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and on-site vaccine access, vaccine promotion through mass media and social media may help 255 
to further overcome these barriers [46]. 256 
 In this study the vaccination coverage in the standard care group (~10%) was 257 
somewhat higher than in previous Hong Kong studies among pregnant women, where rates 258 
ranged from 1.7–6.2% [15, 32, 33]. The influenza vaccination pamphlet provided to 259 
participants in the standard care group was widely available in antenatal clinics. However, it 260 
is not given directly to pregnant women, and it is likely that few read the pamphlet. Therefore, 261 
it is possible that simply being given the influenza vaccination pamphlet by a nurse increased 262 
the women’s risk perceptions and perceived importance of vaccination. Other studies have 263 
shown significant increases in maternal influenza vaccination coverage following the 264 
distribution of education pamphlets by healthcare professionals [23, 55]. In addition, pregnant 265 
women may perceive healthcare staff-delivered information as more personally relevant and 266 
important [56]. Although the effect may be small, actively distributing pamphlets is a simple 267 
action, easily implemented in clinical settings at a minimal cost.  268 
 269 
4.1  Strengths and limitations 270 
This study provides high-quality evidence of the effectiveness of brief education in improving 271 
maternal influenza vaccination rates. First, random allocation and allocation concealment 272 
minimized treatment assignment bias. Second, there was a high participation rate. This might 273 
have been because the study involved only a brief onsite intervention, requiring less than 10 274 
minutes of participants’ time, and a short follow-up telephone interview. Evidence shows that 275 
people are more likely to participate in studies with a low participation burden such as in-276 
person or telephone interviews [57]. Third, as the intervention was delivered immediately 277 
after randomization, we achieved 100% treatment fidelity. Finally, the loss to follow-up rate 278 
was <5%, meaning the risk of attrition bias was minimal.  279 
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This study also has some limitations that need to be considered when interpreting the 280 
findings. First, participants were recruited from the antenatal clinics at four public hospitals; 281 
therefore, the demographic and socioeconomic characteristics might not be representative of 282 
all pregnant women in Hong Kong. When compared with the 2014 Hong Kong female 283 
population from 20-49 years of age, our sample had fewer participants in the lowest education 284 
category (7.2% vs. 17.9%) and more participants in the higher education category (42.4% vs. 285 
30.7%) [58]. Second, the higher-than-expected vaccination rate in the standard care group 286 
might indicate that study participants were more receptive to the influenza vaccination 287 
information than other pregnant women. As the study information sheet, the consent form, 288 
and the education pamphlet all identified that the study was on influenza vaccination, the 289 
standard care group may have also received some priming regarding the importance of 290 
influenza vaccine in pregnancy. Third, although we took measures to minimize potential 291 
contamination between the two treatment groups, we did not assess whether there was 292 
contamination or sharing of information between the participants. Fourth, the H7N9 avian 293 
influenza outbreak may also explain the higher-than-expected vaccination rate in the standard 294 
care group. However, outbreaks of avian influenza are not uncommon in Hong Kong [59] and 295 
these outbreaks have had minimal impact on influenza vaccination rates in various population 296 
and at risk groups [60, 61]. Fifth, it is also possible, as the assessment of the primary outcome 297 
relied on self-reported data, reporting or recall bias may have affected the study results. It was 298 
not possible to verify participants’ vaccination status as most primary care providers work in 299 
solo practices that do not have centralized vaccination reporting systems. However, existing 300 
studies have shown that recall of vaccination status is accurate, and maternal recall is 301 
particularly reliable for pregnancy-related events [62-64]. In addition, the unavailability of 302 
influenza vaccine in the antenatal clinics may have limited the effect of antenatal education as 303 
other barriers such as employment or lack of childcare may have prevented pregnant women 304 
from being vaccinated. Finally, due to the nature of the intervention, participants and the 305 
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research nurse could not be blinded to the treatment allocation and this may have biased the 306 
study in some unmeasurable way. 307 
 308 
4.2  Conclusion 309 
Although our study supports the effectiveness of brief education in improving maternal 310 
influenza vaccination rates, coverage remained low. It is possible that in populations with 311 
higher baseline vaccination rates, brief education may be sufficient to achieve target 312 
vaccination rates. However, in populations such as Hong Kong, where baseline vaccination 313 
rates are low, multi-component interventions are likely required. In addition to education 314 
about influenza vaccination, other supportive practices such as a direct healthcare professional 315 
recommendation, onsite vaccination, and promotion campaigns that specifically address 316 
maternal concerns and fears about vaccination may need to be implemented to reduce barriers 317 
and achieve optimal vaccination coverage. 318 
 319 
Full text of the trial protocol is available at www.biomedcentral.com/1471-2393/14/19 [28]. 320 
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Figure Caption 332 
Figure 1: Flow diagram of participants through each stage of the study 333 
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Table 1.  Baseline Characteristics of Participants by Intervention Group 
Demographic variable 
Standard care 
(n=160), 
No. (%) 
Intervention 
(n=161), 
No. (%) Total (n=321) P 
Maternal age, year M(SD) 33.8  4.3 33.2  4.0 33.5  4.2 .21 
Parity     
    0 99 (61.9) 92 (57.1) 191 (59.5) .69 
    1 53 (33.1) 60 (37.3) 113 (35.2)  
    >=2 8 (5.0) 9 (5.6) 17 (5.3)  
Maternal education     
    Compulsory secondary or below 12 (7.5) 11 (6.8) 23 (7.2) .21 
    Upper secondary 64 (40.0) 68 (42.2) 53 (41.1)  
    Some post-secondary 10 (6.3) 20 (12.4) 30 (9.4)  
    University degree or above 74 (46.3) 62 (38.5) 136 (42.4)  
Place of birth     
    Hong Kong SAR 116 (72.5) 112 (69.6) 228 (71.0) .71 
    Mainland China  41 (25.6) 47 (29.2) 88 (27.4)  
    Others 3 (1.9) 2 (1.2) 5 (1.6)  
Length of residency in Hong Kong     
    <10 years 20 (12.5) 21 (13.0) 41 (12.8) .75 
    10-15 years 26 (16.3) 31 (19.3) 57 (17.8)  
    Since birth 114 (71.3) 109 (67.7) 223 (69.5)  
Family income
1
     
    Below median 44 (27.5) 49 (30.4) 93 (29.0) .56 
    Above median 116 (72.5) 112 (69.6) 228 (71.0)  
Smoked during pregnancy     
    No 158 (98.8) 157 (97.5) 315 (98.1) .69 
    Yes 2 (1.3) 4 (2.5) 6 (1.9)  
Pre-existing chronic illness     
    No 149 (93.1) 134 (83.2) 283 (88.2) .006 
    Yes 11 (6.9) 27 (16.8) 38 (11.8)  
Types: (some participants had >1 
illness) 
   -- 
    Hepatitis B carrier status 3 (27.3) 11 (40.7) 14 (36.8)  
    Respiratory disease 1 (9.1) 5 (18.5) 6 (15.8)  
    Thyroid disease 1 (9.1) 5 (18.5) 6 (15.8)  
    Others 6 (54.5) 7 (25.9) 13 (34.2)  
Pregnancy related health problem     
    No 125 (78.1) 126 (78.3) 251 (78.2) .98 
    Yes 35 (21.9) 35 (21.7) 70 (21.8)  
Types: (some participants had >1 
health problem) 
   -- 
    Gestational diabetes 13 (37.1) 19 (54.3) 32 (45.7)  
    Anaemia 15 (42.9) 13 (37.1) 28 (40.0)  
    Hypertension 2 (5.7) 4 (11.4) 6 (8.6)  
    Others 5 (14.3) 2 (5.7) 7 (10.0)  
1
Median household income in HK in 2011 was $20,000 to $24,999 HKD per month (1USD=7.7HKD) 
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Table 2.  Observed Influenza Vaccine Uptake During Pregnancy by Treatment Group
1
 
  Treatment group, n (%)  
RD, % (95% CI) 
 
P   Standard care  Intervention   
Intention-to-treat analysis
2
 
Vaccinated  16 (10.0)  34 (21.1)     
Non-vaccinated  144 (90.0)  127 (78.9)  11.1 (3.3–19.0)  0.006 
         
Per-protocol analysis
3
 
Vaccinated  16 (10.4)  34 (22.5)     
Non-vaccinated  138 (89.6)  117 (77.5)  12.1 (3.9–20.3)  0.004 
RD=Risk Difference; CI=Confidence Interval 
1
The actual influenza vaccine uptake rate among pregnant women 
2
In the standard care group, n=160. In the intervention group, n=161. 
3
In the standard care group, n=154. In the intervention group, n=151 
Tables
Table 3.  Expected Influenza Vaccine Uptake During Pregnancy by Treatment Groups
1
 
  Treatment group, n (%)  
RD, % (95% CI) 
  
  Standard care  Intervention   P 
Intention-to-treat analysis
2
 
Vaccinated  24 (15.0)  71 (44.1)     
Non-vaccinated  136 (85.0)  90 (55.9)  29.1 (19.6–38.6)  <0.001 
         
Per-protocol analysis
3
 
Vaccinated  24 (15.6)  71 (47.0)     
Non-vaccinated  130 (84.4)  80 (53.0)  31.4 (21.6–41.2)  <0.001 
RD=Risk Difference; CI=Confidence Interval
 
1
The estimated influenza vaccination rate if participants who attempted to be vaccinated had received the 
vaccine 
2
In the standard care group, n=160. In the intervention group, n=161. 
3
In the standard care group, n=154. In the intervention group, n=151 
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